Modern aspects of cutaneous neurogenic inflammation.

Recent findings have shed new light on the role of peripheral nerves in the skin and established a modern concept of cutaneous neurobiology. Closely related monodirectional and/or bidirectional pathways exist in which the central and peripheral nervous system, the endocrine and immune system, and almost all skin cells are involved. Information is emerging about the factors involved in these immunomodulatory mechanisms, which are defined as neuropeptides, neurotransmitters, neurotrophins, and neurohormones. The interaction between peripheral nerves and the immune system is mediated by different types of cutaneous nerve fibers that release neuromediators and activate specific receptors on target cells in the skin such as keratinocytes, mast cells, Langerhans cells, microvascular endothelial cells, fibroblasts, and infiltrating immune cells. These interactions influence a variety of physiologic and pathophysiologic functions including cellular development, growth, differentiation, immunity, vasoregulation, leukocyte recruitment, pruritus, and wound healing. A variety of mechanisms lead to the termination of cellular responses to released neuropeptides under physiologic circumstances. Herein, we highlight some of the recent advances of neurocutaneous biology and discuss the role of nerves in mediating cutaneous inflammation. Understanding the mechanisms and the factors controlling neuromediators and their receptors and degrading enzymes will lead to the identification of novel therapeutic targets for the treatment of cutaneous diseases.

[1]  N. Aiyar,et al.  CGRP stimulates the adhesion of leukocytes to vascular endothelial cells , 1992, Peptides.

[2]  C. Shaw,et al.  Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. , 1991, The Journal of investigative dermatology.

[3]  T. Luger,et al.  Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. , 1997, Journal of immunology.

[4]  T. Luger,et al.  Mechanisms of the Antiinflammatory Effects of α‐MSH: Role of Transcription Factor NF‐κB and Adhesion Molecule Expression , 1999 .

[5]  S. Grando Biological functions of keratinocyte cholinergic receptors. , 1997, The journal of investigative dermatology. Symposium proceedings.

[6]  U. McGovern,et al.  Intracellular calcium as a second messenger following growth stimulation of human keratinocytes , 1995, The British journal of dermatology.

[7]  Bull,et al.  Expression of nerve growth factor receptors in cutaneous inflammation , 1998, The British journal of dermatology.

[8]  D. Groneberg,et al.  Simultaneous detection of receptor mRNA and ligand protein in human skin tissues , 2002, Journal of cutaneous pathology.

[9]  A. Cupisti,et al.  Endothelium-dependent and endothelium-independent skin vasoreactivity in the elderly , 2002, Aging clinical and experimental research.

[10]  B. Iyengar Modulation of melanocytic activity by acetylcholine. , 1989, Acta anatomica.

[11]  P. Stjärne,et al.  PACAP-induced plasma extravasation in rat skin , 1997, Regulatory Peptides.

[12]  A. Blum,et al.  Immunohistochemical localization of muscarinic acetylcholine receptors in primary and metastatic malignant melanomas , 1997, Journal of cutaneous pathology.

[13]  E. G. Erdös,et al.  Neutral endopeptidase in serum samples from patients with adult respiratory distress syndrome. Comparison with angiotensin-converting enzyme. , 1985, The American review of respiratory disease.

[14]  W. Müller,et al.  Muscarinic cholinergic receptors on intact human lymphocytes properties and subclass characterization , 1987, Biological Psychiatry.

[15]  H. Tainio Cytochemical localization of VIP‐stimulated adenylate cyclase activity in human sweat glands , 1987, The British journal of dermatology.

[16]  A. Mauviel,et al.  The Role of Proopiomelanocortin‐Derived Peptides in Skin Fibroblast and Mast Cell Functions , 1999, Annals of the New York Academy of Sciences.

[17]  R. Funk,et al.  Immunohistochemical detection of human skin nerve fibers. , 1997, Acta Histochemica.

[18]  Yoshikatsu Suzuki,et al.  Detection of Skin Over Cysts with Spina bifida May Be Useful Not Only for Preventing Neurological Damage during Labor but Also for Predicting Fetal Prognosis , 2000, Fetal Diagnosis and Therapy.

[19]  A. Slominski,et al.  Neuroendocrinology of the skin. , 2000, Endocrine reviews.

[20]  V. Ferrans,et al.  Influence of α‐melanocyte‐stimulating hormone and of ultraviolet radiation on the transfer of melanosomes to keratinocytes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  K. Nordlind,et al.  Inhibitory effect of vasoactive intestinal peptide on the challenge phase of allergic contact dermatitis in humans. , 1999, Acta dermato-venereologica.

[22]  D. Pozo,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. , 1999, Journal of immunology.

[23]  J. Olerud,et al.  VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. , 1999, Journal of immunology.

[24]  J. Levine,et al.  Noradrenaline hyperalgesia is mediated through interaction with sympathetic postgahglionic neurone terminals rather than activation of primary afferent nociceptors , 1986, Nature.

[25]  T. Williams,et al.  Inflammatory oedema induced by synergism between calcitonin gene‐related peptide (CGRP) and mediators of increased vascular permeability , 1985, British journal of pharmacology.

[26]  M. Delgado,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Collagen-Induced Arthritis: An Experimental Immunomodulatory Therapy1 , 2001, The Journal of Immunology.

[27]  T. Luger Neuromediators--a crucial component of the skin immune system. , 2002, Journal of dermatological science.

[28]  K. H. Kim,et al.  The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor. , 2001, The Journal of investigative dermatology.

[29]  A. Naukkarinen,et al.  Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema , 2003, Archives of Dermatological Research.

[30]  K. Pinkerton,et al.  A Receptor-Mediated Mechanism of Nicotine Toxicity in Oral Keratinocytes , 2001, Laboratory Investigation.

[31]  H. Shigematsu,et al.  Parasympathetic innervation of cutaneous blood vessels by vasoactive intestinal polypeptide-immunoreactive and acetylcholinesterase-positive nerves: Histochemical and experimental study on rat lower lip , 1988, Neuroscience.

[32]  M. Carr,et al.  A Role for TRPV1 in Bradykinin-Induced Excitation of Vagal Airway Afferent Nerve Terminals , 2003, Journal of Pharmacology and Experimental Therapeutics.

[33]  S. Shioda,et al.  Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Its Receptors: Neuroendocrine and Endocrine Interaction , 1995, Frontiers in Neuroendocrinology.

[34]  K. Nordlind,et al.  Vasoactive Intestinal Polypeptide Inhibits the Established Allergic Contact Dermatitis in Humans a , 1996, Annals of the New York Academy of Sciences.

[35]  L. Timmermann,et al.  Involvement of neurokinins in antidromic vasodilatation in hairy and hairless skin of the rat hindlimb , 1999, Neuroscience.

[36]  H. Vaudry,et al.  PACAP Acts as a Neurotrophic Factor During Histogenesis of the Rat Cerebellar Cortex , 2000, Annals of the New York Academy of Sciences.

[37]  B. Ulfhake,et al.  Regulation of NGF‐family ligands and receptors in adulthood and senescence: correlation to degenerative and regenerative changes in cutaneous innervation , 2000, The European journal of neuroscience.

[38]  M. Pittelkow,et al.  Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. , 1994, Biochimica et biophysica acta.

[39]  T. Lundeberg,et al.  Inhibitory effects of tachykinin receptor antagonists on thermally induced inflammatory reactions in a rat model. , 1999, Burns : journal of the International Society for Burn Injuries.

[40]  S. Yamamoto,et al.  Substance P induces tumor necrosis factor-alpha release from human skin via mitogen-activated protein kinase. , 2000, European journal of pharmacology.

[41]  K. Paukkonen,et al.  Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions , 2004, Archives of Dermatological Research.

[42]  D. Payan,et al.  Interactions between neutral endopeptidase (EC 3.4.24.11) and the substance P (NK1) receptor expressed in mammalian cells. , 1994, The Biochemical journal.

[43]  C. Kennedy,et al.  The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin , 1997, The British journal of dermatology.

[44]  L. Misery,et al.  Skin, immunity and the nervous system , 1997, The British journal of dermatology.

[45]  G. Mcgregor,et al.  Expression and distribution of calcitonin receptor-like receptor in human hairy skin , 2002, Peptides.

[46]  M. Hide,et al.  Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro , 1999, Archives of Dermatological Research.

[47]  S. Brain,et al.  Sensory neuropeptides: their role in inflammation and wound healing. , 1997, Immunopharmacology.

[48]  S. Rose-John,et al.  Role of interleukin‐6 and soluble IL‐6 receptor in region‐specific induction of astrocytic differentiation and neurotrophin expression , 1999 .

[49]  I. Tatsuno,et al.  Involvement of PACAP receptor in primary afferent fibre‐evoked responses of ventral roots in the neonatal rat spinal cord , 2001, British journal of pharmacology.

[50]  S. Galli,et al.  Stem cell factor influences neuro-immune interactions: The response of mast cells to pituitary adenylate cyclase activating polypeptide is altered by stem cell factor , 1999, Regulatory Peptides.

[51]  J. Olerud,et al.  Neutral endopeptidase expression and distribution in human skin and wounds. , 1999, The Journal of investigative dermatology.

[52]  D. I. Våge,et al.  The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. , 1996, Recent progress in hormone research.

[53]  K. Bost,et al.  Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS. , 1992, Regional immunology.

[54]  T. Luger,et al.  Modulation of Cutaneous Inflammation by Angiotensin-Converting Enzyme1 , 2003, The Journal of Immunology.

[55]  G. Naumann,et al.  [Immunity and the nervous system]. , 1962, Munchener medizinische Wochenschrift.

[56]  G. D. Hunter,et al.  Proteinase-Activated Receptors , 2001 .

[57]  A. Slominski,et al.  Human keratinocytes express functional α-MSH (MC1-R) receptors , 2001, In Vitro Cellular & Developmental Biology - Animal.

[58]  U. Hipler,et al.  Vasoactive intestinal peptide supports induced migration of human keratinocytes and their colonization of an artificial polyurethane matrix , 1997, Regulatory Peptides.

[59]  J. Olerud,et al.  Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK‐2R) , 2000, Experimental dermatology.

[60]  M. Pittelkow,et al.  Increased in vitro expression of beta2-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients , 2004, Archives of Dermatological Research.

[61]  T. Makino,et al.  Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis , 2002, The British journal of dermatology.

[62]  N. Vergnolle Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. , 1999, Journal of immunology.

[63]  M. Reinecke,et al.  Immunohistochemical localization of vasoactive intestinal polypeptide (VIP) in Merkel cells of various mammals: evidence for a neuromodulator function of the Merkel cell. , 1983, The Journal of investigative dermatology.

[64]  M. Delgado,et al.  VIP and PACAP Inhibit Activation Induced Apoptosis in T Lymphocytes , 2000, Annals of the New York Academy of Sciences.

[65]  Mario Delgado,et al.  Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease , 2001, Nature Medicine.

[66]  Thomas A. Luger,et al.  Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin , 2003, The Journal of Neuroscience.

[67]  M. Schultzberg,et al.  Somatostatin- and factor XIIIa-immunoreactive cells in psoriasis during clobetasol propionate and calciprotriol treatment. , 1999, Acta dermato-venereologica.

[68]  F. Legat,et al.  The cutaneous neurosensory system in skin disease. , 2002, Advances in dermatology.

[69]  T. Williams,et al.  The partial inhibition of inflammatory responses induced by capsaicin using the fab fragment of a selective calcitonin gene-related peptide antiserum in rabbit skin , 1992, Neuroscience.

[70]  J. Wagner,et al.  Catecholamines Inhibit the Antigen-Presenting Capability of Epidermal Langerhans Cells1 , 2002, The Journal of Immunology.

[71]  K. Schallreuter,et al.  Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis. , 1997, The journal of investigative dermatology. Symposium proceedings.

[72]  K. Sato,et al.  Effect of VIP on sweat secretion and cAMP accumulation in isolated simian eccrine glands. , 1987, The American journal of physiology.

[73]  S. Brain New feelings about the role of sensory nerves in inflammation , 2000, Nature Medicine.

[74]  L. Misery,et al.  Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P , 1997, Archives of Dermatological Research.

[75]  J. Olerud,et al.  Dermatitis P-Induced Inflammation in Allergic Contact Neutral Endopeptidase Terminates Substance , 2000 .

[76]  I. Black,et al.  Expression of catecholaminergic characteristics by primary sensory neurons in the normal adult rat in vivo. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[77]  M. Simon,et al.  alpha-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. , 1996, Journal of immunology.

[78]  H. Vaudry,et al.  Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. , 2000, Pharmacological reviews.

[79]  B. Gilchrest,et al.  Innervation of melanocytes in human skin , 1996, The Journal of experimental medicine.

[80]  L. Kemény,et al.  Effects of the Neuropeptides Substance P, Calcitonin Gene-Related Peptide and α-Melanocyte-Stimulating Hormone on the IL-8/IL-8 Receptor System in a Cultured Human Keratinocyte Cell Line and Dermal Fibroblasts , 1999, Inflammation.

[81]  J. Haycock,et al.  α‐MSH Immunomodulation Acts via Rel/NF‐κB in Cutaneous and Ocular Melanocytes and in Melanoma Cells , 1999 .

[82]  S. L. Dun,et al.  Pituitary adenylate cyclase activating polypeptide-immunoreactivity in human spinal cord and dorsal root ganglia , 1996, Brain Research.

[83]  B. Zelickson,et al.  Agarose gel keratinocyte outgrowth system as a model of skin re-epithelization: requirement of endogenous acetylcholine for outgrowth initiation. , 1993, The Journal of investigative dermatology.

[84]  S. Eichmüller,et al.  Neural mechanisms of hair growth control. , 1997, The journal of investigative dermatology. Symposium proceedings.

[85]  T. Luger,et al.  Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. , 2003, Endocrinology.

[86]  T. Luger,et al.  Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1. , 2000, The Journal of investigative dermatology.

[87]  D. Metcalfe,et al.  Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. , 1999, Journal of immunology.

[88]  Cioca Daniel Petru,et al.  Apoptosis of peripheral blood lymphocytes is induced by catecholamines. , 2000, Japanese heart journal.

[89]  J. Olerud,et al.  Interactions of the skin and nervous system. , 1997, Journal of Investigative Dermatology Symposium Proceedings.

[90]  J. Wallace,et al.  Agonists of proteinase‐activated receptor 1 induce plasma extravasation by a neurogenic mechanism , 2001, British journal of pharmacology.

[91]  C. Wiedermann,et al.  Stimulation of the chemotactic migration of human fibroblasts by substance P. , 1993, European journal of pharmacology.

[92]  M. Kress,et al.  Topical acetyl salicylate and dipyrone attenuate neurogenic protein extravasation in rat skin in vivo , 2000, Neuroscience Letters.

[93]  G. Calo’,et al.  B1 and B2 kinin receptors in various species. , 1997, Immunopharmacology.

[94]  J. Cockcroft,et al.  Pituitary Adenylate Cyclase Activating Polypeptide is a Potent Vasodilator in Humans , 1992, Journal of cardiovascular pharmacology.

[95]  G. Chrousos,et al.  Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects. , 1998, Endocrinology.

[96]  T. Williams,et al.  Interactions between the tachykinins and calcitonin gene‐related peptide lead to the modulation of oedema formation and blood flow in rat skin , 1989, British journal of pharmacology.

[97]  T. X. Lee,et al.  Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. , 1996, The Journal of investigative dermatology.

[98]  C. Shaw,et al.  The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high‐performance liquid chromatography , 1994, Clinical and experimental dermatology.

[99]  A. Johnson,et al.  Cytokines increase neutral endopeptidase activity in lung fibroblasts. , 1993, American journal of respiratory cell and molecular biology.

[100]  Ruoyan Chen,et al.  Macrophages, But Not T and B Lymphocytes, Are Critical for Subepidermal Blister Formation in Experimental Bullous Pemphigoid: Macrophage-Mediated Neutrophil Infiltration Depends on Mast Cell Activation1 , 2002, The Journal of Immunology.

[101]  R. Granstein,et al.  Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. , 2002, Methods.

[102]  R. Buchli,et al.  Identification and Mapping of Keratinocyte Muscarinic Acetylcholine Receptor Subtypes in Human Epidermis1 , 1998 .

[103]  J. Warren,et al.  Opposing roles of cyclic AMP in the vascular control of edema formation , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  F. Fantini,et al.  Nerve growth factor is increased in psoriatic skin. , 1995, The Journal of investigative dermatology.

[105]  A. Chakraborty,et al.  The effect of thioredoxin on the expression of proopiomelanocortin-derived peptides, the melanocortin 1 receptor and cell survival of normal human keratinocytes. , 2001, The journal of investigative dermatology. Symposium proceedings.

[106]  U. Wahn,et al.  Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. , 2003, The Journal of allergy and clinical immunology.

[107]  J. Haycock,et al.  Inhibition of Tumor Necrosis Factor-α Stimulated NFκB/p65 in Human Keratinocytes by α-Melanocyte Stimulating Hormone and Adrenocorticotropic Hormone Peptides , 2002 .

[108]  S. Bischoff,et al.  Opposing effects of tumor necrosis factor‐α and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N‐formyl‐methionyl‐leucyl‐phenylalanine , 1992, European journal of immunology.

[109]  J. Szolcsányi Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of an unorthodox neuroregulatory mechanism. , 1996, Progress in brain research.

[110]  M. Mukoyama,et al.  Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy. , 2000, Biochemical and biophysical research communications.

[111]  C. Wiedermann,et al.  Induction of endothelial cell differentiation into capillary-like structures by substance P. , 1996, European journal of pharmacology.

[112]  J. Warren,et al.  Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo , 1992, British journal of pharmacology.

[113]  E. Pintér,et al.  Neurokinin-1 Receptor Agonists Are Involved in Mediating Neutrophil Accumulation in the Inflamed, But Not Normal, Cutaneous Microvasculature: An In Vivo Study Using Neurokinin-1 Receptor Knockout Mice1 , 2000, The Journal of Immunology.

[114]  D. Michikami,et al.  Interrelations of vasoconstrictor sympathetic outflow to skin and core temperature during unilateral sole heating in humans , 2001, Autonomic Neuroscience.

[115]  M. Schaller,et al.  Endothelium-Dependent Vasodilation in the Skin Microcirculation of Patients with Septic Shock , 2003, Shock.

[116]  J. Pisegna Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Its Receptor , 2003 .

[117]  J. Kessler,et al.  Cytokine regulation of substance P expression in sympathetic neurons. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[118]  R. Plevin,et al.  Proteinase-activated Receptor-2-mediated Activation of Stress-activated Protein Kinases and Inhibitory κB Kinases in NCTC 2544 Keratinocytes* , 2001, The Journal of Biological Chemistry.

[119]  D. Pozo,et al.  Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activation Polypeptide (PACAP) Protect Mice from Lethal Endotoxemia Through the Inhibition of TNF-α and IL-6 , 1999, The Journal of Immunology.

[120]  J. Wallace,et al.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.

[121]  K. Nishioka,et al.  Substance P augments fibrogenic cytokine-induced fibroblast proliferation: possible involvement of neuropeptide in tissue fibrosis. , 1997, Journal of dermatological science.

[122]  T. Luger,et al.  Molecular Basis of the α‐MSH/IL‐1 Antagonism , 1999 .

[123]  C. Stein,et al.  Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo , 1992, Neuroscience.

[124]  M. Spaargaren,et al.  Regulation of Cytokine Signaling by B Cell Antigen Receptor and Cd40-Controlled Expression of Heparan Sulfate Proteoglycans , 2000, The Journal of experimental medicine.

[125]  J. M. Lipton,et al.  The Neuropeptide α‐MSH in Host Defense , 2000 .

[126]  T. Williams,et al.  VASOACTIVE INTESTINAL POLYPEPTIDE IS MORE POTENT THAN PROSTAGLANDIN E2 AS A VASODILATOR AND OEDEMA POTENTIATOR IN RABBIT SKIN , 1982, British journal of pharmacology.

[127]  I. Gozes,et al.  VIP and the potent analog, stearyl‐Nle17‐VIP, induce proliferation of keratinocytes , 2000, FEBS letters.

[128]  J. M. Lipton,et al.  NF-κB activation is inhibited in human pulmonary epithelial cells transfected with α-melanocyte-stimulating hormone vector , 2000, Peptides.

[129]  A. Arimura,et al.  Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). , 1993, Biochemical and biophysical research communications.

[130]  J. Mazurkiewicz,et al.  Cutaneous expression of corticotropin‐releasing hormone (CRH), urocortin, and CRH receptors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[131]  S. Galli,et al.  Mast cells contribute to PACAP-induced dermal oedema in mice , 1999, Regulatory Peptides.

[132]  A. Haegerstrand,et al.  Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[133]  S. Brain,et al.  Lack of a significant effect of deletion of the tachykinin neurokinin-1 receptor on wound healing in mouse skin , 2001, Neuroscience.

[134]  J. Seckl,et al.  Distribution of neuropeptides in dorsal root ganglia of the rat; substance P, somatostatin and calcitonin gene-related peptide , 1993, Neuroscience Letters.

[135]  Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. , 1996, Endocrine reviews.

[136]  M. Steinhoff,et al.  Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis , 1999, Regulatory Peptides.

[137]  E. Albuquerque,et al.  A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. , 1995, The Journal of investigative dermatology.

[138]  J. Brown,et al.  Substance P selectively activates TNF-alpha gene expression in murine mast cells. , 1993, Journal of immunology.

[139]  A. Schmidt-Choudhury,et al.  Pituitary Adenylate Cyclase Activating Polypeptide Induces Degranulation of Rat Peritoneal Mast Cells via High‐Affinity PACAP Receptor‐Independent Activation of G Proteins , 1998, Annals of the New York Academy of Sciences.

[140]  D. Julius,et al.  The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.

[141]  C. Wahlestedt,et al.  Vascular effects of proteinase-activated receptor 2 agonist peptide. , 1997, Journal of vascular research.

[142]  S. Grando,et al.  Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. , 1997, Research communications in molecular pathology and pharmacology.

[143]  C. Stroh,et al.  Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. , 2002, The Journal of investigative dermatology.

[144]  E. Pintér,et al.  Interaction between interleukin 1β and endogenous neurokinin 1 receptor agonists in mediating plasma extravasation and neutrophil accumulation in the cutaneous microvasculature of the rat , 2002, Neuroscience Letters.

[145]  F. Sundler,et al.  Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: Immunocytochemical and immunochemical evidence , 1993, Neuroscience.

[146]  J. Vishwanatha,et al.  Effects of smokeless tobacco on chemically transformed hamster oral keratinocytes: role of angiotensin I-converting enzyme. , 1994, Carcinogenesis.

[147]  T. Luger,et al.  The Role of α‐MSH as a Modulator of Cutaneous Inflammation , 2000 .

[148]  J. Haycock,et al.  α-Melanocyte-stimulating Hormone Reduces Impact of Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on Keratinocyte and Melanoma Cell Lines* , 2000, The Journal of Biological Chemistry.

[149]  E. Muñoz-Elías,et al.  Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun* , 1998, The Journal of Biological Chemistry.

[150]  L. Misery,et al.  Langerhans cells in the neuro-immuno-cutaneous system , 1998, Journal of Neuroimmunology.

[151]  L. Kemény,et al.  Alpha-melanocyte stimulating hormone induces collagenase/matrix metalloproteinase-1 in human dermal fibroblasts. , 1995, Biological chemistry Hoppe-Seyler.

[152]  D. Gruenert,et al.  Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. , 1991, The American journal of physiology.

[153]  D. Pozo,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide modulate endotoxin‐induced IL‐6 production by murine peritoneal macrophages , 1998, Journal of leukocyte biology.

[154]  G. Wendelschafer‐Crabb,et al.  Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. , 1995, The Journal of investigative dermatology.

[155]  M. Steinhoff,et al.  Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. , 1998, American journal of physiology. Cell physiology.

[156]  A. Kagey‐Sobotka,et al.  Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. , 1996, Clinical immunology and immunopathology.

[157]  D. Borson Roles of neutral endopeptidase in airways. , 1991, The American journal of physiology.

[158]  C. Créminon,et al.  Neurogenic responses mediated by vanilloid receptor‐1 (TRPV1) are blocked by the high affinity antagonist, iodo‐resiniferatoxin , 2003, British journal of pharmacology.

[159]  K. Nordlind,et al.  Vasoactive intestinal polypeptide in allergic contact dermatitis: an immunohistochemical and radioimmunoassay study , 1999, Archives of Dermatological Research.

[160]  J. Hoxie,et al.  Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2* , 1997, The Journal of Biological Chemistry.

[161]  N. Bunnett,et al.  Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. , 1999, Journal of immunology.

[162]  T. Lee,et al.  Cutaneous responses to vasoactive intestinal polypeptide in chronic idiopathic urticaria , 1992, The Lancet.

[163]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[164]  S. Chang,et al.  Vasoactive intestinal polypeptide stimulates the proliferation of HaCaT cell via TGF- α , 1999, Neuropeptides.

[165]  T. Luger,et al.  alpha-Melanocyte stimulating hormone acts as a selective inducer of secretory functions in human mast cells. , 2000, Biochemical and biophysical research communications.

[166]  C. Estrada,et al.  Neuronal Nitric Oxide Synthase Activation by Vasoactive Intestinal Peptide in Bovine Cerebral Arteries , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[167]  J. Genard,et al.  Renal hemodynamics and blood flow autoregulation during acute cyclooxygenase inhibition in male rats. , 1995, The American journal of physiology.

[168]  T. Luger,et al.  The Pilosebaceous Unit Is Part of the Skin Immune System , 1998, Dermatology.

[169]  M. Macey,et al.  Immunolocalization of protease‐activated receptor‐2 in skin: receptor activation stimulates interleukin‐8 secretion by keratinocytes in vitro , 1998, Immunology.

[170]  J. Olerud,et al.  Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function. , 1998, American journal of physiology. Cell physiology.

[171]  Williams Tj,et al.  Neuropharmacology of peptides in skin. , 1988 .

[172]  H. Viinamäki,et al.  Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. , 1993, Psychotherapy and psychosomatics.

[173]  B. Seegal,et al.  Angiotensin-converting enzyme: vascular endothelial localization. , 1976, Science.

[174]  L. Petersen,et al.  Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells , 1998, Inflammation Research.

[175]  M. Macey,et al.  Protease-activated receptors and their role in IL-6 and NF-IL-6 expression in human gingival fibroblasts. , 1998, Journal of periodontal research.

[176]  R. Freeman,et al.  Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation. , 2002, Journal of applied physiology.

[177]  E. Antunes,et al.  The effect of a tachykinin NK1 receptor antagonist, SR140333, on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider , 1996, British journal of pharmacology.

[178]  A. Haegerstrand,et al.  Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.